ClinConnect ClinConnect Logo
Search / Trial NCT02872389

Power Spectral Analysis of EEG During Equi-MAC Inhalation Anesthesia

Launched by KANGBUK SAMSUNG HOSPITAL · Aug 15, 2016

Trial Information

Current as of July 21, 2025

Completed

Keywords

ClinConnect Summary

Volatile anesthetics vary in their relative hypnotic potency. Recent studies demonstrated that equi-minimum alveolar concentration of various volatile anesthetic agents may produce different spectral entropy or bispectral index values. However, there were no studies that demonstrate the difference of hypnotic potency using power spectral analysis of electroencephalographic signals (e.g., spectral edge frequency 95%, total power, % value of each bandage). The purpose of this clinical trial is to compare hypnotic effect of sevoflurane and desflurane at equal minimum alveolar concentrations us...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients undergoing arthroscopic knee surgery under general anesthesia using volatile anesthetics
  • patients with american society of anesthesiologist physical status I, II
  • patients aged 19-65 years
  • patients obtaining written informed consent
  • Exclusion Criteria:
  • patients with a history of any psychiatric or neurological disease
  • patients who had received any medication affecting the central nervous system
  • patients who had received medication affecting the sympathetic or parasympathetic nervous systems
  • patients undergoing tracheal intubation for airway management
  • pregnant women

About Kangbuk Samsung Hospital

Kangbuk Samsung Hospital is a leading healthcare institution in South Korea, renowned for its commitment to advanced medical research and clinical excellence. As a sponsor of clinical trials, the hospital integrates cutting-edge technology and innovative therapies to enhance patient care and outcomes. With a multidisciplinary team of experienced researchers and healthcare professionals, Kangbuk Samsung Hospital is dedicated to conducting rigorous clinical studies that adhere to the highest ethical standards. Its focus on translational medicine aims to bridge the gap between laboratory findings and clinical applications, ultimately contributing to the advancement of medical science and improving therapeutic options for patients.

Locations

Seoul, , Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Kyoungho Ryu, M.D.

Principal Investigator

Kangbuk Samsung Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials